Despite a chilling economy, at least seven biotechs and biopharmas have posted sizable IPOs in 2023. Compared with last year, however, it’s clear that the industry is still in an IPO drought.
Tag Archive for: Life sciences
Regulatory affairs teams within lifescience organizations possess a unique opportunity to drive connected intelligence across the enterprise to support critical operations relating to drug development, safety, and regulatory verticals.
The new structure strengthens offerings and drives the addition of diversified marketing services.
The deal will allow both companies to offer cohesive end-to-end commercial solutions to the life sciences industry. The partnership includes Havas Health & You taking a minority investment in Trinity.
Klick Group announced today that longtime McKinsey & Company executive Brian C. Fox has joined as President to help lead the company’s growth as the premier provider of end-to-end commercialization services for life sciences companies. Fox brings deep expertise in market strategy, product launches, sales force effectiveness, medical affairs, market access, clinical development, and corporate affairs.
Changes are ahead for professionals in life sciences sales and marketing, and medical affairs. From the widening gap between AI-users and those companies still holding out; to the next evolution in AI, and how companies will seek to make it more practical on a global scale; to the impact of AI on leveraging digital opinion leaders to get more clinical evidence in the hands of doctors, Aktana offers its predictions for the coming year.
The acquisition, which is expected to close in the first half of 2023, according to a joint statement on Sunday, comes amid a slowdown in merger and acquisitions activity in the U.S. life sciences sector.
As the economy ebbs and flows, pharma and biotech companies alike are feeling the pressure to cut costs. From rapid inflation to the ever-changing regulatory landscape, many are looking for ways to reduce their burn rate.
Marketing acceleration company demonstrates 893 percent growth over three years to join America’s fastest-growing private companies.
When seamlessly collaborating with partners on the same cloud-based safety solution, sponsors have real-time visibility and control while driving more efficient and faster processes. Easily scaling with more studies or data, modern pharmacovigilance (PV) applications are intuitive and designed for teams to work together globally.
